Bank of Nova Scotia
RVMD icon

Bank of Nova Scotia’s Revolution Medicines RVMD Stock Holding History

Bank of Nova Scotia’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
73,879
+63,574
+617% +$9.29M 0.02% 422
2026
Q1 		$1M Sell
10,305
-115,608
-92% -$11.7M ﹤0.01% 830
2025
Q4 		$10M Buy
+125,913
New +$8.26M 0.01% 479

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bank of Nova Scotia's RVMD Position: Q2 2026 in Review

Bank of Nova Scotia increased its Revolution Medicines (RVMD) stake by 617% in Q2 2026, buying an estimated $9.29M and bringing the position to 73,879 shares worth $13.8M. The position accounts for 0.02% of the portfolio, ranked #422.

Bank of Nova Scotia first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bank of Nova Scotia held 73,879 shares of Revolution Medicines worth $13.8M as of Q2 2026.
  • Bank of Nova Scotia bought 63,574 Revolution Medicines shares in Q2 2026, an estimated $9.29M.
  • Revolution Medicines made up 0.02% of Bank of Nova Scotia's portfolio in Q2 2026, its #422 holding.
  • Bank of Nova Scotia first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.